Literature DB >> 7441555

Reduced inhibition during epileptiform activity in the in vitro hippocampal slice.

R Dingledine, L Gjerstad.   

Abstract

1. Intracellular recordings were made from CA1 pyramidal cells in the hippocampal slice in vitro. The responses to orthodromic and antidromic activation and to ionophoretically applied GABA were studied. 2. The epileptogenic agent sodium benzyl penicillin reduced the recurrent i.p.s.p. evoked by subthreshold antidromic stimulation. Reversal potential studies of the i.p.s.p. and resistance measurements showed that this reduction was mainly due to a decrease in i.p.s.p. conductance. 3. Penicillin also reduced the conductance and associated membrane potential changes induced by ejecting GABA near the soma or into the apical dendritic region. 4. The mixed e.p.s.p.-i.p.s.p. evoked by orthodromic stimulation was converted to a pure depolarizing potential as the i.p.s.p. was blocked. Concurrently the probability of discharge to a constant orthodromic stimulus was increased. Similar changes were seen in a low chloride solution. 5. The time course of the reduction of inhibition was similar to that of the enhanced orthodromic response seen after penicillin treatment. 6. We conclude that reduction of postsynaptic inhibition is partly responsible for the increased probability of orthodromic discharge caused by penicillin. The longer latency all-or-nothing burst seen in some cells, however, seems to require an additional mechanism, although reduced inhibition may facilitate the triggering of this burst.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441555      PMCID: PMC1282973          DOI: 10.1113/jphysiol.1980.sp013364

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Cortical intracellular potentials and their responses to strychnine.

Authors:  C L LI
Journal:  J Neurophysiol       Date:  1959-07       Impact factor: 2.714

2.  CORTICAL CELLULAR PHENOMENA IN EXPERIMENTAL EPILEPSY: INTERICTAL MANIFESTATIONS.

Authors:  H MATSUMOTO; C A MARSAN
Journal:  Exp Neurol       Date:  1964-04       Impact factor: 5.330

3.  CORTICAL INHIBITORY POSTSYNAPTIC POTENTIALS AND STRYCHNINIZATION.

Authors:  D A POLLEN; C A MARSAN
Journal:  J Neurophysiol       Date:  1965-03       Impact factor: 2.714

4.  Central actions of benzodiazepines.

Authors:  D R Curtis; D Lodge; G A Johnston; S J Brand
Journal:  Brain Res       Date:  1976-12-17       Impact factor: 3.252

5.  Penicillin-induced spinal seizures: selective effects on synaptic transmission.

Authors:  J Davenport; P C Schwindt; W E Crill
Journal:  Exp Neurol       Date:  1977-07       Impact factor: 5.330

6.  The anionic permeability of the inhibitory postsynaptic membrane of hippocampal pyramidal cells.

Authors:  J Eccles; R A Nicoll; T Oshima; F J Rubia
Journal:  Proc R Soc Lond B Biol Sci       Date:  1977-09-19

7.  Common synaptic effects of pentylenetetrazol and penicillin.

Authors:  W A Wilson; A V Escueta
Journal:  Brain Res       Date:  1974-05-31       Impact factor: 3.252

8.  Action of penicillin on inhibitory processes in the cat's cortex.

Authors:  H Van Duijn; P A Schwartzkroin; D A Prince
Journal:  Brain Res       Date:  1973-04-27       Impact factor: 3.252

9.  Cortical inhibition and gamma-aminobutyric acid.

Authors:  J J Dreifuss; J S Kelly; K Krnjević
Journal:  Exp Brain Res       Date:  1969       Impact factor: 1.972

10.  Antagonism of gamma-aminobutyric acid and glycine by convulsants in the cuneate nucleus of cat.

Authors:  R G Hill; M A Simmonds; D W Straughan
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

View more
  38 in total

1.  Participation of interneurons in penicillin-induced epileptic discharges.

Authors:  R Domann; S Uhlig; T Dorn; O W Witte
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  The GABAA receptor-mediated recurrent inhibition in ventral compared with dorsal CA1 hippocampal region is weaker, decays faster and lasts less.

Authors:  Theodoros Petrides; Panagiotis Georgopoulos; George Kostopoulos; Costas Papatheodoropoulos
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

3.  A decrease in firing threshold observed after induction of the EPSP-spike (E-S) component of long-term potentiation in rat hippocampal slices.

Authors:  L E Chavez-Noriega; J V Halliwell; T V Bliss
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

4.  On the contribution of KCC2 and carbonic anhydrase to two types of in vitro interictal discharge.

Authors:  Shabnam Hamidi; Margherita D'Antuono; Massimo Avoli
Journal:  Pflugers Arch       Date:  2015-01-22       Impact factor: 3.657

5.  Alterations of inhibitory processes in the dentate gyrus following kindling-induced epilepsy.

Authors:  M W Oliver; J J Miller
Journal:  Exp Brain Res       Date:  1985       Impact factor: 1.972

Review 6.  Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy.

Authors:  J G Tasker; F E Dudek
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

7.  The cause of the imbalance in the neuronal network leading to seizure activity can be predicted by the electrographic pattern of the seizure onset.

Authors:  Anatol Bragin; Avetis Azizyan; Joyel Almajano; Jerome Engel
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 8.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

9.  Evidence for GABA as the transmitter for early cortically evoked inhibition of cat caudate neurons.

Authors:  P L Herrling
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

10.  Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid.

Authors:  P Andersen; R Dingledine; L Gjerstad; I A Langmoen; A M Laursen
Journal:  J Physiol       Date:  1980-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.